15 min listen
NEJM Interview: Dr. Walid Gellad on strategies for managing the cost of drugs receiving accelerated FDA approval.
FromNEJM Interviews
NEJM Interview: Dr. Walid Gellad on strategies for managing the cost of drugs receiving accelerated FDA approval.
FromNEJM Interviews
ratings:
Length:
10 minutes
Released:
May 24, 2017
Format:
Podcast episode
Description
Dr. Walid Gellad is an associate professor of medicine and health policy and codirector of the Center for Pharmaceutical Policy and Prescribing at the University of Pittsburgh. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. W.F. Gellad and A.S. Kesselheim. Accelerated Approval and Expensive Drugs - A Challenging Combination. N Engl J Med 2017;376:2001-4.
Released:
May 24, 2017
Format:
Podcast episode
Titles in the series (100)
NEJM Interview: Dr. Jerry Avorn on the evolving approach to drug safety in the United States by NEJM Interviews